Related Experiment Video
Updated: Jun 27, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Parental Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Predominates Over Coinfected SARS-CoV-2 Delta,
Kyeongbin Baek1, Dongbum Kim2, Bo Min Kang1
1Department of Microbiology, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
Abstract:
The evolution of SARS-CoV-2, which limits public control and treatment, seems to have occurred through multiple mechanisms, including recombination of cocirculating strains in hosts. However, insufficient experimental data have been obtained after coinfection. Therefore, we investigated the emergence of variants after coinfection with parental SARS-CoV-2 and the SARS-CoV-2 Delta. We found that fewer (approximately 50%) mutations accumulated in Calu-3 cells than in other cells after serial passaging. Previously, we established a long-term replication mouse model by infecting Calu-3 cell-derived xenograft tumors with SARS-CoV-2. Here, we utilized our model to investigate the outcome after coinfection. More diverse viral mutations, along with multiple high-frequency simultaneous mutations, were discovered in the tumors than during cell passaging. Viral isolates from the tumors showed no cytopathic effects and formed much smaller plaques. Phylogenetic analysis suggested that the genetic makeup of the variants remained largely the same as that of parental SARS-CoV-2 rather than the SARS-CoV-2 Delta. Viral challenge revealed that the isolates were less lethal than the parental SARS-CoV-2 and SARS-CoV-2 Delta strains. These findings suggest that parental SARS-CoV-2 predominates over the SARS-CoV-2 Delta when coinfected, but the SARS-CoV-2 Delta contributes to the evolution of parental SARS-CoV-2 variants toward better host adaptation without recombination.
Insights
Parental SARS-CoV-2 dominates during coinfection, driving the evolution of variants with improved host adaptation. SARS-CoV-2 Delta contributes to this adaptation without direct genetic recombination.
Area of Science:
- Virology
- Evolutionary Biology
- Infectious Diseases
Background:
- SARS-CoV-2 evolution, including recombination, poses challenges for public health control and treatment.
- Coinfection with different SARS-CoV-2 strains is a potential driver of viral evolution, but experimental data are limited.
Purpose of the Study:
- To investigate the emergence and characteristics of SARS-CoV-2 variants following coinfection with parental SARS-CoV-2 and the Delta variant.
- To assess the role of a long-term replication mouse model in studying SARS-CoV-2 coinfection dynamics.
Main Methods:
- Coinfection of Calu-3 cells and a Calu-3 cell-derived xenograft mouse model with parental SARS-CoV-2 and SARS-CoV-2 Delta.
- Serial passaging in cell culture and in vivo tumor models.
- Analysis of viral mutations, plaque formation, cytopathic effects, and phylogenetic relationships.
- Assessment of viral lethality through challenge studies.
Main Results:
- Fewer mutations accumulated in cell passaging compared to the mouse model.
- Tumor isolates exhibited diverse mutations and high-frequency simultaneous mutations, with no observed cytopathic effects or small plaque formation.
- Phylogenetic analysis indicated variants retained the genetic makeup of parental SARS-CoV-2, not the Delta variant.
- Viral isolates were less lethal than parental and Delta strains.
Conclusions:
- Parental SARS-CoV-2 predominates over the Delta variant during coinfection.
- SARS-CoV-2 Delta facilitates the evolution of parental SARS-CoV-2 variants towards enhanced host adaptation without recombination.
- The mouse xenograft model is valuable for studying SARS-CoV-2 evolution during coinfection.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Coronavirus
Respiratory Syncytial Virus Disease